Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Inolimomab for acute Graft versus Host Disease	Inolimomab (Leukotac; B-B10; BT563)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease including combined pulmonary fibrosis and emphysema	Treprostinil (Tyvaso; LIQ861; Orenitram; UT-15C; Remodulin; treprostinil sodium)	Pulmonary hypertension	Cardiovascular System , Respiratory System	2024	View \| Download
Inhaled Lipid‐complexed Cisplatin for Pulmonary Relapse of Osteosarcoma	Cisplatin SR (Cisplatin liposomal inhaled)	Bone sarcoma	Sarcoma	2018	View \| Download
Infigratinib for unresectable locally advanced or metastatic cholangiocarinoma with FGFR2 rearrangements – second line	Infigratinib (BGJ398; BGJ-398; Truseltiq)	Cholangiocarcinoma	Gastrointestinal Cancer	2021	View \| Download
Inebilizumab for neuromyelitis optica spectrum disorders	Inebilizumab (MEDI551)	Neuromyelitis optica spectrum disorders	Neurology	2024	View \| Download
Inebilizumab for Neuromyelitis optica	Inebilizumab (MEDI551)	Neuromyelitis optica , Neuromyelitis optica spectrum disorders	Neurology , Ophthalmology	2018	View \| Download
Inclisiran for primary hypercholesterolaemia and mixed dyslipidaemia	Inclisiran (ALN-PCSsc; ALN-60212)	Heterozygous familial hypercholesterolaemia (HeFH) , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders , Genetic Disorders	2019	View \| Download
Inavolisib with palbociclib and fulvestrant for treating HR+/HER2-, PIK3CA mutated locally advanced or metastatic breast cancer	Fulvestrant (Faslodex) , Inavolisib (GDC 0077;RG 6114) , Palbociclib (Ibrance; PD-0332991)	Breast cancer	Breast Cancer	2024	View \| Download
Imlunestrant with or without abemaciclib for treating ER-positive, HER2-negative locally advanced or metastatic breast cancer after endocrine therapy	Imlunestrant	Breast cancer	Breast Cancer	2023	View \| Download
Imlifidase for kidney transplantation in highly sensitised patients with chronic kidney disease	Imlifidase (IdeS)	Chronic kidney disease (CKD)	Cardiovascular System , Nephrology	2019	View \| Download